Multiple Endocrine Neoplasia Type 4

Description

Multiple endocrine neoplasia type 4 (MEN4) is a very rare form of MEN (see this term), an inherited cancer syndrome, characterized by parathyroid and anterior pituitary tumors, possibly associated with adrenal, renal, and reproductive organ tumors.

Clinical Features

Top most frequent phenotypes and symptoms related to Multiple Endocrine Neoplasia Type 4

  • Neoplasm
  • Hypertension
  • Diarrhea
  • Diabetes mellitus
  • Hypothyroidism
  • Carcinoma
  • Erythema
  • Type II diabetes mellitus
  • Abnormality of the urinary system
  • Hypercalcemia

And another 42 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Multiple Endocrine Neoplasia Type 4 Is also known as men4.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Multiple Endocrine Neoplasia Type 4 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories (United States).

RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)

View the complete list with 612 more genes
Specificity
1 %
Genes
50 %
Hereditary Paraganglioma/Pheochromocytoma Panel.

By Baylor Miraca Genetics Laboratories (United States).

SDHA, SDHB, SDHC, SDHD, VHL, SDHAF2, TMEM127, MAX, RET
Specificity
12 %
Genes
50 %
Hereditary Endocrine Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

SDHA, SDHB, SDHC, SDHD, TP53, VHL, CDC73, SDHAF2, TMEM127, MAX, MEN1, PRKAR1A, PTEN, RET
Specificity
8 %
Genes
50 %
Comprehensive Hereditary Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

RUNX1, SDHA, SDHB, SDHC, SDHD, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, VHL, WT1, CBL, SUFU, CDC73, CDH1, CDK4, CDKN1C, CDKN2A , (...)

View the complete list with 39 more genes
Specificity
2 %
Genes
50 %
MEN2 (RET) DNA Sequencing Test.

By Athena Diagnostics Inc (United States).

RET
Specificity
100 %
Genes
50 %
Pheochromocytoma Evaluation.

By Athena Diagnostics Inc (United States).

SDHB, VHL, RET
Specificity
34 %
Genes
50 %
Multiple endocrine neoplasia, type 2.

By Center for Human Genetics, Inc (United States).

RET
Specificity
100 %
Genes
50 %
Multiple Endocrine Neoplasia Type 2.

By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital (United States).

RET
Specificity
100 %
Genes
50 %

You can get up to 289 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM MESH ORPHANET Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SPINOCEREBELLAR ATAXIA 26; SCA26 SKRABAN-DEARDORFF SYNDROME; SKDEAS LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A MICROTIA-ANOTIA CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB ANXIETY